NEW YORK (360Dx) – NX Prenatal said today it has entered a strategic collaboration with Milu Labs to commercialize its test in Asia for the risk of preterm birth.

Milu will help launch the NX Prenatal test in countries including China as it pursues efforts to develop a diagnostics business in Asia focused on maternal fetal medicine and women's health.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.